Status:
COMPLETED
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aims of the study were to find vascular markers of inflammation and endothelial damage during the course of severe sepsis in septic patients and the effects of treatment with anti-inflammatory medicat...
Detailed Description
During the past years many investigators have focused on the immunological changes in sepsis disease, and great attention has been paid to the development of practicable means of immunomonitoring. Hum...
Eligibility Criteria
Inclusion
- SIRS-Criteria
- Proven Infection
- One sepsis-induced organ-failure
- Adults \<18 years old
Exclusion
- Anemia
- Pregnancy
- Blood donor in the last 3 month
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00222222
Start Date
March 1 2003
End Date
December 1 2011
Last Update
February 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1. Medical Department
University Hospital Mannheim, Mannheim, Germany, 68167